Saturday 17 October 2026
Export CODX’s income statement to Excel — free account
Co-Diagnostics, Inc.
CODX Healthcare Medical Devices
Co-Diagnostics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $622,500.00, down 84.1% from fiscal 2024. In the quarter to June 2026, revenue grew 1.96%, EPS grew 78.9% and free cash flow grew 17.5%, each against the same quarter a year earlier.
0.65
0.07
−9.72%
Follow CODX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 7 | 5 | 4 | 3 | 3 | 2 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 6.50 | 6.97 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 465.82 | 69.69 | 3.33 | 2.63 | 2.33 | 6.11 | 5.81 | 10.83 |
Altman Z-Score |
— | 15.39 | (26.56) | (4.98) | 37.20 | 8.85 | 6.43 | 1.88 | (0.88) | (9.74) |
Altman Z″-Score (non-manufacturers) |
— | (4.90) | (71.62) | (47.09) | 26.03 | 12.76 | 18.36 | 10.73 | 2.46 | (16.26) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 9.06 | 6.37 | 15.48 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (30.45) | (19.35) | (9.29) | 12.44 | 52.80 | (19.84) | (8.71) | (2.76) | (1.09) |
Beneish M-Score |
— | — | — | 1.48 | 306.15 | 0.39 | (4.29) | (4.44) | (4.28) | 2.24 |
P/B ratio |
— | 7.85 | 0.00 | 8.62 | 3.72 | 1.92 | 0.69 | 0.48 | 0.42 | 0.33 |
Price to Tangible BV |
— | 7.85 | 0.00 | 8.62 | 3.72 | 2.78 | 0.91 | 0.70 | 0.82 | 0.50 |
EV/Sales |
— | 0.00 | 442.01 | 65.53 | 2.70 | 1.71 | (0.05) | (2.48) | (1.79) | (8.26) |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 4.80 | 3.61 | 0.16 | 0.41 | 0.18 | 0.10 |
EV/Operating CF |
— | (8.31) | (4.32) | (2.55) | 7.13 | 4.08 | (0.26) | 0.77 | 0.24 | 0.18 |
EV/FCF |
— | (7.99) | (4.28) | (2.48) | 7.34 | 4.15 | (0.33) | 0.72 | 0.23 | 0.17 |
Quick Ratio |
0.26 | 5.63 | 0.41 | 3.12 | 14.63 | 8.79 | 22.35 | 10.24 | 4.08 | 3.42 |
Current Ratio |
0.31 | 7.09 | 0.45 | 4.83 | 16.69 | 9.14 | 23.94 | 10.81 | 4.41 | 3.87 |
Net Debt/EBITDA |
0.34 | 0.78 | 0.16 | 0.15 | (1.13) | (1.94) | 7.88 | 1.41 | 0.77 | 0.24 |
Debt/Assets |
34.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.15) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.01 | 0.11 | 2.03 | 0.85 | 0.24 | 0.06 | 0.05 | 0.01 |
Operating CF/Net income |
0.68 | 0.46 | 0.65 | 0.89 | 0.66 | 1.12 | (0.46) | 0.63 | 0.77 | 0.62 |
Capex/Depreciation |
(0.33) | (2.82) | (0.81) | (1.72) | (5.59) | (2.00) | (0.09) | (1.11) | (0.54) | (0.63) |
Interest Coverage |
(7.01) | (14.71) | (45.35) | (55.39) | 428.95 | 1,010.20 | (38.32) | — | — | — |
| (450.68%) | (1,626.17%) | (449.31%) | (1,826.53%) | 124.14% | 36.45% | (11.44%) | (35.24%) | (53.81%) | (125.89%) | |
| (64.74%) | (233.60%) | (201.81%) | (328.81%) | 115.66% | 31.70% | (10.06%) | (32.36%) | (47.38%) | (106.21%) | |
ROIC |
0.00% | (902.71%) | 0.00% | (436.34%) | 134.43% | 64.53% | (50.70%) | (97.18%) | (103.83%) | (358.57%) |
Return on Tangible Assets |
75.65% | (174.45%) | 548.23% | (426.40%) | 65.65% | 35.10% | (15.58%) | (59.45%) | (135.70%) | (377.40%) |
Average Days of Receivables |
0.00 | 0.00 | 122.58 | 223.07 | 59.42 | 77.71 | 56.79 | 17.73 | 12.36 | 137.73 |
Research and Development Expense of Revenue |
0.00% | 13,028.57% | 3,411.53% | 637.86% | 4.27% | 15.29% | 50.96% | 337.09% | 535.85% | 3,074.25% |
Selling, General and Administrative Expense of Revenue |
0.00% | 45,746.75% | 11,870.68% | 2,120.42% | 17.36% | 25.49% | 63.15% | 310.34% | 527.19% | 1,837.65% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.22 | 0.28 | 0.41 | 0.29 |
Share Based Compensation of Revenue |
0.00% | 26,415.58% | 3,339.35% | 506.23% | 3.67% | 5.63% | 22.04% | 122.39% | 138.82% | 382.83% |
Graham Net Nets |
— | 0.12 | (0.08) | 0.07 | 0.25 | 0.35 | 1.06 | 1.27 | 0.99 | 1.42 |
Graham Number |
— | 0.00 | 29.40 | 0.00 | 269.12 | 347.79 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (23.03%) | (33.75%) | (41.38%) | 15.39% | 14.35% | (18.20%) | (85.30%) | (165.50%) | (699.25%) |
Free Cash Flow Yield |
— | (11.05%) | (22.17%) | (37.89%) | 11.03% | 15.69% | 6.46% | (56.32%) | (131.43%) | (442.41%) |
Revenue per Share |
0.00 | 0.02 | 0.10 | 0.39 | 83.79 | 101.81 | 32.64 | 6.97 | 3.87 | 0.47 |
Operating CF per Share |
(3.99) | (8.80) | (9.81) | (9.90) | 31.65 | 42.73 | 6.27 | (22.60) | (28.83) | (21.90) |
Capex per Share |
(0.04) | (0.35) | (0.10) | (0.20) | (0.87) | (0.70) | (1.36) | (1.40) | (0.74) | (0.53) |
Free Cash Flow per Share |
(4.02) | (9.15) | (9.91) | (10.10) | 30.78 | 42.03 | 4.90 | (23.99) | (29.57) | (22.43) |
Cash per Share |
3.03 | 9.68 | 2.29 | 1.60 | 53.17 | 93.46 | 77.52 | 59.91 | 29.42 | 8.93 |
Shareholders Equity per Share |
(9.10) | 10.55 | (2.55) | 3.11 | 74.96 | 139.86 | 109.24 | 88.02 | 53.28 | 15.51 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(9.10) | 10.55 | (2.55) | 3.11 | 74.96 | 139.86 | 109.24 | 88.02 | 53.28 | 15.51 |
Free Cash Flow |
(1.32) | (3.34) | (4.12) | (5.64) | 27.39 | 40.41 | 5.14 | (23.45) | (29.90) | (29.84) |
Working Capital |
(2.64) | 3.82 | (1.30) | 1.26 | 63.75 | 102.52 | 88.86 | 56.39 | 24.98 | 10.15 |
Capital Expenditures |
(0.01) | (0.13) | (0.04) | (0.11) | (0.77) | (0.67) | (1.43) | (1.37) | (0.75) | (0.70) |
Net Current Asset Value |
(3.08) | 3.64 | (1.56) | 1.11 | 63.27 | 89.56 | 84.17 | 52.83 | 22.60 | 9.58 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 4.82 | 3.64 | 0.06 | 0.40 | 0.17 | 0.10 |
Capex to Sales |
0.00 | 16.79 | 1.04 | 0.53 | 0.01 | 0.01 | 0.04 | 0.20 | 0.19 | 1.12 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 5.95 | 5.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.43 | 0.28 | 0.33 | 0.33 | 0.15 | 0.17 | 6.56 | 0.41 | 0.50 | 0.49 |
Cash ROIC |
85.40% | (45.24%) | 3,794.94% | (214.35%) | 24.03% | 18.01% | 2.63% | (16.22%) | (35.76%) | (91.77%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 4.81 | 2.97 | 12.15 | 5.94 | 2.62 | 2.41 | 16.89 | 3.39 |
Accounts Payable Turnover |
0.51 | 0.00 | 0.10 | 1.45 | 54.91 | 19.20 | 7.03 | 3.44 | 0.42 | 0.09 |
Inventory Turnover |
0.00 | 0.02 | 0.69 | 1.04 | 4.05 | 2.32 | 1.50 | 1.20 | 0.73 | 0.22 |
Average Days of Payables |
1,021.03 | 49,640.00 | 5,785.64 | 19.48 | 13.16 | 19.16 | 63.42 | 129.27 | 1,203.50 | 3,082.48 |
Days of Inventory on Hand |
0.00 | 11,071.67 | 706.70 | 640.37 | 175.89 | 63.20 | 353.64 | 145.19 | 391.89 | 1,628.71 |
Average Receivables |
0.01 | — | 0.01 | 0.07 | 6.13 | 16.49 | 13.08 | 2.83 | 0.23 | 0.18 |
Average Payables |
0.07 | 0.07 | 0.09 | 0.08 | 0.30 | 0.60 | 0.78 | 1.22 | 2.39 | 2.59 |
Average Inventory |
— | 0.01 | 0.01 | 0.11 | 4.10 | 5.00 | 3.66 | 3.49 | 1.37 | 1.03 |
Average Assets |
2.98 | 2.98 | 3.11 | 1.88 | 36.73 | 115.64 | 141.56 | 109.20 | 79.44 | 44.15 |
Average Common Equity |
0.43 | 0.43 | 1.40 | 0.34 | 34.22 | 100.59 | 124.50 | 100.27 | 69.94 | 37.25 |
Columns are period end dates